AGNARGENICA THERAPEUTICS LIMITEDMarket sensitive

Clinical Advisory Committee Established to Advance Phase 2b

Date and time
Announcement type
Company Update
Show details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASXOpen original PDFAGN announcement history

Recent AGN announcements